-
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Valk, A. M., Keijser, J. B. D., van Dam, K. P. J., Stalman, E. W., Wieske, L., Steenhuis, M., Kummer, L. Y. L., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., Horváth, B., Hijnen, D-J., Schreurs, C. R. G., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., & 10 others, Jul 2024, In: Allergy: European Journal of Allergy and Clinical Immunology. 79, 7, p. 1952-1961 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
van den Dijssel, J., Duurland, M. C., Konijn, V. A. L., Kummer, L. Y. L., Hagen, R. R., Kuijper, L. H., Wieske, L., van Dam, K. P. J., Stalman, E. W., Steenhuis, M., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Menage, C., Koets, L., Veldhuisen, B., Verstegen, N. J. M., van der Schoot, C. E., van Esch, W. J. E., D'Haens, G. R. AM., & 10 others, 1 Apr 2024, In: Journal of autoimmunity. 144, 103175.Research output: Contribution to journal › Article › Academic › peer-review
-
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection
Keijzer, S., Oskam, N., Ooijevaar-de Heer, P., Steenhuis, M., Keijser, J. B. D., Wieske, L., van Dam, K. P. J., Stalman, E. W., Kummer, L. Y. L., Boekel, L., Kuijpers, T. W., ten Brinke, A., van Ham, S. M., Eftimov, F., Tas, S. W., Wolbink, G. J. & Rispens, T., 2024, In: Frontiers in immunology. 15, 1314507.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
